AMN Healthcare Services, Inc.
NYSE:AMNMedical - Care Facilities
-$1.29 today
- Market cap
- $1.45B
- Beta
- 0.44
- P/E (TTM)
- -37.3
- EPS (TTM)
- -$0.83
Volume 0.55M
Average 1.02M
AMN Accounts Receivables
Cash effect of the change in amounts owed by customers; growing receivables consume cash.
AMN Healthcare Services, Inc.NYSE: AMN
Accounts Receivables · Q1 FY2026 · quarter ended Mar 2026
Accounts receivables turns negative
Q1 FY2026 accounts receivables was -$14.19M, compared with $24.51M a year earlier. Trailing-twelve-month accounts receivables was $41.69M. Over 3 fiscal years it compounded at +55.1% a year.
Context
- Accounts receivables amounted to 2.7% of revenue in FY2025, down 4.6 pp from a year earlier.
- Accounts receivables increased in 1 of the last 3 fiscal years.
What to watch
Whether quarterly accounts receivables holds near -$14.19M or moves back toward the trailing-twelve-month quarterly average of $10.42M.
Sources:Cash FlowText generated from reported figures; not investment advice.
Accounts Receivables history
USD · from the cash flow
- Latest · FY2025
- 74.75M USD
- Year-over-year change
- -65.9%
| Period | Period end | Accounts Receivables | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 74.75M | -65.9% |
| FY2024 | 2024-12-31 | 219.44M | -2.4% |
| FY2023 | 2023-12-31 | 224.85M | +1022.1% |
| FY2022 | 2022-12-31 | 20.04M | +103.4% |
| FY2021 | 2021-12-31 | (585.27M) | — |
Accounts Receivables vs competitors
How AMN compares with its peers on the latest reported figures
- AMN's LTM Mar 2026 accounts receivables of $41.69M is the 3rd largest of the 11 companies compared; the peer median is $1.65M.
- Its year-over-year change of -76.5% is the 7th highest of 10, against a peer median of -17.5%.
- Accounts receivables amounts to 1.2% of revenue for AMN, versus a peer median of 2.3%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Mar 2026 | $85.22M | +3185.5% | — | 4.5% | |
| LTM Mar 2026 | $46.51M | -80.1% | — | 5.3% | |
| LTM Mar 2026 | $41.69M | -76.5% | +55.1% | 1.2% | |
| LTM Mar 2026 | $7.53M | -241.6% | -20.0% | 2.4% | |
| LTM Mar 2026 | $6.2M | -10.1% | +30.2% | 6.0% | |
| LTM Jun 2026 | $3.47M | -166.1% | — | 1.7% | |
| LTM Mar 2026 | $3.3M | -17.5% | -7.0% | 0.4% | |
| LTM Mar 2026 | $2.98M | +212.5% | — | 2.1% | |
| LTM Mar 2026 | $1.39M | +158.3% | — | 0.9% | |
| LTM Dec 2025 | $354K | -70.4% | — | — | |
| LTM Mar 2026 | $0 | — | — | — | |
| Peer median (excluding AMN) | $1.65M | -17.5% | -7.0% | 2.3% | |
Competitors are the stored peer set for AMN. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Cash Flow Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Net Income | 327.39M | 444.05M | 210.68M | (146.98M) | (95.7M) |
| Depreciation & Amortization | 103.7M | 137.11M | 160.93M | 173.78M | 156.6M |
| Deferred Income Tax | (16.29M) | (24.62M) | (12.93M) | (51.07M) | (19.55M) |
| Stock-Based Compensation | 25.22M | 30.07M | 18.02M | 23.32M | 30.68M |
| Change in Working Capital | (143.49M) | (558K) | (50.13M) | 85.91M | 101.03M |
| Accounts Receivables | (585.27M) | 20.04M | 224.85M | 219.44M | 74.75M |
| Inventory | (256.12M) | 0 | 0 | 0 | 0 |
| Accounts Payables | 256.12M | 0 | 0 | 0 | (20.57M) |
| Other Working Capital | 441.77M | (20.6M) | (274.98M) | (133.53M) | 46.85M |
| Other Non-Cash Items | 8.84M | 67.68M | 45.6M | 235.46M | 96.39M |
| Operating Cash Flow | 305.36M | 653.73M | 372.17M | 320.42M | 269.46M |
| Capital Expenditures | (53.66M) | (80.92M) | (105.39M) | (80.89M) | (35.63M) |
| Acquisitions (Net) | (41.26M) | (69.5M) | (292.1M) | 0 | 65.28M |
| Purchases of Investments | (61.22M) | (13.15M) | 0 | (1.38M) | (36.15M) |
| Sales of Investments | 57.74M | 14.38M | 9.89M | 9.1M | 10.78M |
| Other Investing Activities | (8.99M) | (26.61M) | (26.6M) | (6.76M) | 22K |
| Investing Cash Flow | (107.4M) | (170.71M) | (412.49M) | (79.94M) | 4.3M |
| Debt Repayment | (21.88M) | 0 | 459.7M | (250M) | (285M) |
| Common Stock Issued | 0 | 0 | 0 | 0 | 0 |
| Common Stock Repurchased | (2.69M) | (576.77M) | (424.74M) | (8.48M) | (2.09M) |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 |
| Other Financing Activities | (10.33M) | (15.1M) | (24.23M) | (9.45M) | (8.8M) |
| Financing Cash Flow | (34.9M) | (591.87M) | 10.73M | (259.45M) | (295.89M) |
| Effect of Forex Changes | (335K) | 0 | 0 | 0 | 0 |
| Net Change in Cash | 162.72M | (108.84M) | (29.6M) | (18.97M) | (22.13M) |
| Free Cash Flow | 251.69M | 572.81M | 266.78M | 239.53M | 233.83M |
AMN Healthcare Services, Inc.
NYSE:AMN
Intrinsic Alpha fair value
Locked
Current Price
$37.60
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.